Miller Financial Services’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$431K Sell
17,891
-50
-0.3% -$1.31K 0.35% 84
2026
Q1
$504K Sell
17,941
-340
-2% -$9.05K 0.55% 61
2025
Q4
$455K Buy
18,281
+300
+2% +$7.57K 0.53% 55
2025
Q3
$458K Sell
17,981
-212
-1% -$5.23K 0.53% 59
2025
Q2
$441K Buy
18,193
+830
+5% +$19.4K 0.56% 58
2025
Q1
$440K Buy
17,363
+1,133
+7% +$29.6K 0.63% 53
2024
Q4
$431K Buy
+16,230
New +$440K 0.36% 85

Other funds holding PFE

Miller Financial Services's PFE Position: Q2 2026 in Review

Miller Financial Services reduced its Pfizer (PFE) stake by 0.28% in Q2 2026, selling an estimated $1.31K and leaving 17,891 shares worth $431K. The position accounts for 0.35% of the portfolio, ranked #84.

Miller Financial Services first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $504K in Q1 2026. 1,199 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Miller Financial Services held 17,891 shares of Pfizer worth $431K as of Q2 2026.
  • Miller Financial Services sold 50 Pfizer shares in Q2 2026, an estimated $1.31K.
  • Pfizer made up 0.35% of Miller Financial Services's portfolio in Q2 2026, its #84 holding.
  • Miller Financial Services first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Miller Financial Services's Pfizer position peaked at $504K in Q1 2026.
  • 1,199 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Miller Financial Services's 13F filing for Q2 2026, filed 29 Jul 2026.